PCI High Potent Manufacturing
LB Bohle – 10.06.2025
Temax_Krautz

Current Edition

Current Edition

Subsection - CDMO

Examining how innovative technologies, integrated manufacturing approaches and AI are shaping manufacturing.

Continue reading

Subsection - Injectables

Exploring advances in injectable drug delivery and sterile manufacturing, designed to improve patient-centric delivery.

Continue reading

Subsection - Neurodegenerative Diseases

Exploring emerging approaches to neurodegenerative disease research and treatment.

Continue reading

Subsection - Nasal & Pulmonary

Highlighting how advances in nasal and pulmonary drug delivery, formulation, devices and analytics are enabling more complex therapies.

Continue reading

Advertisement

CPHI 2027
DDL 2026

Advertisement

Nipro August 26

Advertisement

Merxin March 2026

Advertisement

Aurisco 300×250

Advertisement

Lifecore Biomedical

Research shows new technique could cut time to detect polio in half

This is the first time that this type of scientific method has been used to detect polio.

A new Medicines and Healthcare Products Regulatory Agency (MHRA)-supported study has revealed that direct molecular detection and nanopore sequencing (DDNS) could significantly reduce the detection time for polio.

Researchers at the Institut National de Recherche Biomédicale in Kinshasa have proved, for the first time, that using DDNS to detect polio outbreaks can reduce detection time and reduce costs for public health authorities.

Researchers implemented DDNS in the Democratic Republic of the Congo (DRC), where the outbreak of polio originated, and enabled samples to be tested in the country, reducing costs and delays in transport and testing from 42 days to 19 days.

Currently, samples from countries with active polio outbreaks are shipped around the world for laboratory tests to confirm polio cases.

Javier Martin, principal scientist in virology at MHRA, said: “By implementing detection methods such as DDNS, we can identify where outbreaks are and which polio strain is present much more quickly, allowing us to act at the earliest opportunity.”

Across a six-month period, researchers found that DDNS tests done locally in the DRC were an average of 23 days faster than the standard method, with over 99% accuracy.

The study was conducted in collaboration with the MHRA, Imperial College London, the University of Edinburgh, various World Health Organization (WHO) laboratories, the Global Polio Laboratory Network (GPLN), and was supported by the Bill and Melinda Gates Foundation.

Professor Placide Mbala-Kingebeni, medical doctor and virologist, at Institut National de Recherche Biomédicale, said: “Collaboration and training with our partners has empowered the local team not only to master and confidently carry out this new technique but also to transfer the knowledge and skills to other African countries where poliovirus outbreaks are reported regularly.”

MHRA scientists will continue to support the testing and validation of DDNS as a polio detection technique and will train WHO laboratories on how to use it.

Advertisement

MedPharm 16/07

Advertisement

Biopharma group march 2026

Advertisement

Silgan March 2026

Advertisement

Terumo 06/26

Advertisement

Scott Pharma – 25.03.2025

Advertisement

Bespak

Advertisement

Solstice

Advertisement

Bachem skyscraper
Tjoapack
Aptar – 08/01/2026